Jim Simons Fsd Pharma Inc. Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.6 $36,380 - $54,400	-34,000 Reduced 33.14%	68,600 $83,000
Q2 2023 Aug 11, 2023	BUY	$0.99 - $2.04 $33,264 - $68,544	33,600 Added 48.7%	102,600 $118,000
Q1 2023 May 12, 2023	BUY	$0.77 - $1.81 $7,546 - $17,738	9,800 Added 16.55%	69,000 $107,000
Q4 2022 Feb 13, 2023	SELL	$0.73 - $1.07 $365 - $535	-500 Reduced 0.84%	59,200 $47,000
Q3 2022 Nov 14, 2022	BUY	$0.78 - $1.02 $702 - $918	900 Added 1.53%	59,700 $49,000

Q2 2022 Aug 12, 2022	BUY	$0.78 - $1.1 $20,436 - $28,820	26,200 Added 80.37%	58,800 $46,000
Q1 2022 May 13, 2022	BUY	$0.82 - $1.1 $15,825 - $21,230	19,300 Added 145.11%	32,600 $28,000
Q4 2021 Feb 11, 2022	BUY	$0.96 - $1.63 $12,768 - $21,679	13,300 New	13,300 $14,000
Q1 2021 May 13, 2021	SELL	$1.65 - $3.87 $76,172 - $178,658	-46,165 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.36 - $2.7 $62,784 - $124,645	46,165 New	46,165 $72,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.73M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.